CN1273364A - Detection method of special DNA chip for diagnosis of pathogenic bacteria and disease-related gene mutation - Google Patents
Detection method of special DNA chip for diagnosis of pathogenic bacteria and disease-related gene mutation Download PDFInfo
- Publication number
- CN1273364A CN1273364A CN 99104669 CN99104669A CN1273364A CN 1273364 A CN1273364 A CN 1273364A CN 99104669 CN99104669 CN 99104669 CN 99104669 A CN99104669 A CN 99104669A CN 1273364 A CN1273364 A CN 1273364A
- Authority
- CN
- China
- Prior art keywords
- dna
- array
- electrode
- hybridization
- disease
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000000018 DNA microarray Methods 0.000 title claims abstract description 19
- 238000001514 detection method Methods 0.000 title claims abstract description 19
- 201000010099 disease Diseases 0.000 title claims abstract description 17
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title claims abstract description 17
- 206010064571 Gene mutation Diseases 0.000 title claims abstract description 16
- 244000052616 bacterial pathogen Species 0.000 title abstract description 5
- 238000003745 diagnosis Methods 0.000 title abstract description 3
- 238000000034 method Methods 0.000 claims abstract description 40
- 238000009396 hybridization Methods 0.000 claims abstract description 29
- 239000010931 gold Substances 0.000 claims abstract description 22
- 229910052737 gold Inorganic materials 0.000 claims abstract description 22
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 21
- 238000002848 electrochemical method Methods 0.000 claims abstract description 4
- 238000004377 microelectronic Methods 0.000 claims abstract description 4
- 238000012545 processing Methods 0.000 claims abstract description 4
- 239000004065 semiconductor Substances 0.000 claims abstract description 4
- 239000000523 sample Substances 0.000 claims description 41
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 claims description 21
- 230000009471 action Effects 0.000 claims description 14
- 244000052769 pathogen Species 0.000 claims description 12
- 238000013461 design Methods 0.000 claims description 11
- 230000001717 pathogenic effect Effects 0.000 claims description 11
- 230000008569 process Effects 0.000 claims description 11
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 claims description 7
- 229910052804 chromium Inorganic materials 0.000 claims description 6
- 239000011651 chromium Substances 0.000 claims description 6
- 239000012141 concentrate Substances 0.000 claims description 5
- 239000002094 self assembled monolayer Substances 0.000 claims description 4
- 239000013545 self-assembled monolayer Substances 0.000 claims description 4
- -1 sulfhydryl compound Chemical class 0.000 claims description 4
- 238000009413 insulation Methods 0.000 claims description 3
- 238000001179 sorption measurement Methods 0.000 claims description 3
- 239000010409 thin film Substances 0.000 claims description 3
- 125000003368 amide group Chemical group 0.000 claims description 2
- 238000004519 manufacturing process Methods 0.000 claims description 2
- 238000012986 modification Methods 0.000 claims description 2
- 230000004048 modification Effects 0.000 claims description 2
- 238000007747 plating Methods 0.000 claims description 2
- 229910052581 Si3N4 Inorganic materials 0.000 claims 1
- 238000000926 separation method Methods 0.000 claims 1
- HQVNEWCFYHHQES-UHFFFAOYSA-N silicon nitride Chemical compound N12[Si]34N5[Si]62N3[Si]51N64 HQVNEWCFYHHQES-UHFFFAOYSA-N 0.000 claims 1
- 238000004458 analytical method Methods 0.000 abstract description 8
- 230000035772 mutation Effects 0.000 abstract description 6
- 239000003298 DNA probe Substances 0.000 abstract description 3
- 108020003215 DNA Probes Proteins 0.000 abstract description 2
- 239000011521 glass Substances 0.000 abstract description 2
- 238000005516 engineering process Methods 0.000 abstract 1
- 108020004414 DNA Proteins 0.000 description 21
- 230000008859 change Effects 0.000 description 20
- 229940079593 drug Drugs 0.000 description 11
- 239000003814 drug Substances 0.000 description 11
- 241000193830 Bacillus <bacterium> Species 0.000 description 7
- 238000004070 electrodeposition Methods 0.000 description 7
- 230000003321 amplification Effects 0.000 description 5
- 238000003199 nucleic acid amplification method Methods 0.000 description 5
- 108700012359 toxins Proteins 0.000 description 5
- 241001646719 Escherichia coli O157:H7 Species 0.000 description 4
- 238000010586 diagram Methods 0.000 description 4
- AEUTYOVWOVBAKS-UWVGGRQHSA-N ethambutol Chemical compound CC[C@@H](CO)NCCN[C@@H](CC)CO AEUTYOVWOVBAKS-UWVGGRQHSA-N 0.000 description 4
- 239000003053 toxin Substances 0.000 description 4
- 231100000765 toxin Toxicity 0.000 description 4
- 241000588724 Escherichia coli Species 0.000 description 3
- 206010022653 Intestinal haemorrhages Diseases 0.000 description 3
- 241000607142 Salmonella Species 0.000 description 3
- 241000191967 Staphylococcus aureus Species 0.000 description 3
- 241000607626 Vibrio cholerae Species 0.000 description 3
- 108091008146 restriction endonucleases Proteins 0.000 description 3
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
- 102100023912 40S ribosomal protein S12 Human genes 0.000 description 2
- 229920001817 Agar Polymers 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- 101710146739 Enterotoxin Proteins 0.000 description 2
- 238000012408 PCR amplification Methods 0.000 description 2
- 239000008272 agar Substances 0.000 description 2
- 101150024831 ahpC gene Proteins 0.000 description 2
- 238000003491 array Methods 0.000 description 2
- 238000001378 electrochemiluminescence detection Methods 0.000 description 2
- 229960000285 ethambutol Drugs 0.000 description 2
- 239000001963 growth medium Substances 0.000 description 2
- 101150070420 gyrA gene Proteins 0.000 description 2
- 239000002609 medium Substances 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 238000007894 restriction fragment length polymorphism technique Methods 0.000 description 2
- 108010092841 ribosomal protein S12 Proteins 0.000 description 2
- JQXXHWHPUNPDRT-WLSIYKJHSA-N rifampicin Chemical compound O([C@](C1=O)(C)O/C=C/[C@@H]([C@H]([C@@H](OC(C)=O)[C@H](C)[C@H](O)[C@H](C)[C@@H](O)[C@@H](C)\C=C\C=C(C)/C(=O)NC=2C(O)=C3C([O-])=C4C)C)OC)C4=C1C3=C(O)C=2\C=N\N1CC[NH+](C)CC1 JQXXHWHPUNPDRT-WLSIYKJHSA-N 0.000 description 2
- 229960001225 rifampicin Drugs 0.000 description 2
- 101150090202 rpoB gene Proteins 0.000 description 2
- 230000000405 serological effect Effects 0.000 description 2
- 229910052710 silicon Inorganic materials 0.000 description 2
- 239000010703 silicon Substances 0.000 description 2
- UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 201000008827 tuberculosis Diseases 0.000 description 2
- DOIVPHUVGVJOMX-UHFFFAOYSA-N 1,10-phenanthroline;ruthenium Chemical compound [Ru].C1=CN=C2C3=NC=CC=C3C=CC2=C1.C1=CN=C2C3=NC=CC=C3C=CC2=C1.C1=CN=C2C3=NC=CC=C3C=CC2=C1 DOIVPHUVGVJOMX-UHFFFAOYSA-N 0.000 description 1
- 108020004465 16S ribosomal RNA Proteins 0.000 description 1
- 102220615425 40S ribosomal protein S13_K43R_mutation Human genes 0.000 description 1
- 102220615430 40S ribosomal protein S13_K88Q_mutation Human genes 0.000 description 1
- 102220581634 Actin, cytoplasmic 1_H526Y_mutation Human genes 0.000 description 1
- 108700028369 Alleles Proteins 0.000 description 1
- 101000654311 Androctonus australis Alpha-mammal toxin AaH2 Proteins 0.000 description 1
- 101000583076 Anemonia sulcata Delta-actitoxin-Avd1c Proteins 0.000 description 1
- 208000003643 Callosities Diseases 0.000 description 1
- 108030002440 Catalase peroxidases Proteins 0.000 description 1
- 229920000742 Cotton Polymers 0.000 description 1
- 102000053602 DNA Human genes 0.000 description 1
- 230000004544 DNA amplification Effects 0.000 description 1
- 238000001712 DNA sequencing Methods 0.000 description 1
- 102000004163 DNA-directed RNA polymerases Human genes 0.000 description 1
- 108090000626 DNA-directed RNA polymerases Proteins 0.000 description 1
- LTMHDMANZUZIPE-AMTYYWEZSA-N Digoxin Natural products O([C@H]1[C@H](C)O[C@H](O[C@@H]2C[C@@H]3[C@@](C)([C@@H]4[C@H]([C@]5(O)[C@](C)([C@H](O)C4)[C@H](C4=CC(=O)OC4)CC5)CC3)CC2)C[C@@H]1O)[C@H]1O[C@H](C)[C@@H](O[C@H]2O[C@@H](C)[C@H](O)[C@@H](O)C2)[C@@H](O)C1 LTMHDMANZUZIPE-AMTYYWEZSA-N 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 101000761697 Hemachatus haemachatus Short neurotoxin 1 Proteins 0.000 description 1
- 101000588937 Heteractis magnifica Delta-stichotoxin-Rpa1a Proteins 0.000 description 1
- 206010020649 Hyperkeratosis Diseases 0.000 description 1
- 101000829171 Hypocrea virens (strain Gv29-8 / FGSC 10586) Effector TSP1 Proteins 0.000 description 1
- 101100038261 Methanococcus vannielii (strain ATCC 35089 / DSM 1224 / JCM 13029 / OCM 148 / SB) rpo2C gene Proteins 0.000 description 1
- 241000187479 Mycobacterium tuberculosis Species 0.000 description 1
- 101000800755 Naja oxiana Alpha-elapitoxin-Nno2a Proteins 0.000 description 1
- 108091034117 Oligonucleotide Proteins 0.000 description 1
- 108700020796 Oncogene Proteins 0.000 description 1
- 102000003992 Peroxidases Human genes 0.000 description 1
- 102000007456 Peroxiredoxin Human genes 0.000 description 1
- 108010017898 Shiga Toxins Proteins 0.000 description 1
- 101000640206 Tityus serrulatus Alpha-mammal toxin Ts2 Proteins 0.000 description 1
- 102220538517 Tumor necrosis factor receptor type 1-associated DEATH domain protein_S531L_mutation Human genes 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- 238000004220 aggregation Methods 0.000 description 1
- 238000007844 allele-specific PCR Methods 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 229960002685 biotin Drugs 0.000 description 1
- 235000020958 biotin Nutrition 0.000 description 1
- 239000011616 biotin Substances 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 235000019504 cigarettes Nutrition 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- LTMHDMANZUZIPE-PUGKRICDSA-N digoxin Chemical compound C1[C@H](O)[C@H](O)[C@@H](C)O[C@H]1O[C@@H]1[C@@H](C)O[C@@H](O[C@@H]2[C@H](O[C@@H](O[C@@H]3C[C@@H]4[C@]([C@@H]5[C@H]([C@]6(CC[C@@H]([C@@]6(C)[C@H](O)C5)C=5COC(=O)C=5)O)CC4)(C)CC3)C[C@@H]2O)C)C[C@@H]1O LTMHDMANZUZIPE-PUGKRICDSA-N 0.000 description 1
- 229960005156 digoxin Drugs 0.000 description 1
- LTMHDMANZUZIPE-UHFFFAOYSA-N digoxine Natural products C1C(O)C(O)C(C)OC1OC1C(C)OC(OC2C(OC(OC3CC4C(C5C(C6(CCC(C6(C)C(O)C5)C=5COC(=O)C=5)O)CC4)(C)CC3)CC2O)C)CC1O LTMHDMANZUZIPE-UHFFFAOYSA-N 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000001962 electrophoresis Methods 0.000 description 1
- 108040007096 enoyl-[acyl-carrier-protein] reductase activity proteins Proteins 0.000 description 1
- 239000000147 enterotoxin Substances 0.000 description 1
- 231100000655 enterotoxin Toxicity 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000007850 fluorescent dye Substances 0.000 description 1
- 238000001215 fluorescent labelling Methods 0.000 description 1
- 229940124307 fluoroquinolone Drugs 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 238000001948 isotopic labelling Methods 0.000 description 1
- 230000002906 microbiologic effect Effects 0.000 description 1
- 230000000869 mutational effect Effects 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 101150114893 oxyR gene Proteins 0.000 description 1
- 229940072417 peroxidase Drugs 0.000 description 1
- 108040007629 peroxidase activity proteins Proteins 0.000 description 1
- 108030002458 peroxiredoxin Proteins 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 229960005206 pyrazinamide Drugs 0.000 description 1
- IPEHBUMCGVEMRF-UHFFFAOYSA-N pyrazinecarboxamide Chemical compound NC(=O)C1=CN=CC=N1 IPEHBUMCGVEMRF-UHFFFAOYSA-N 0.000 description 1
- 101150085857 rpo2 gene Proteins 0.000 description 1
- 101150098466 rpsL gene Proteins 0.000 description 1
- 238000001338 self-assembly Methods 0.000 description 1
- 101150050955 stn gene Proteins 0.000 description 1
- 229960005322 streptomycin Drugs 0.000 description 1
- YFTHZRPMJXBUME-UHFFFAOYSA-N tripropylamine Chemical compound CCCN(CCC)CCC YFTHZRPMJXBUME-UHFFFAOYSA-N 0.000 description 1
Images
Landscapes
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
The utility model discloses a new detection method of a DNA chip special for pathogenic bacteria and disease related gene mutation diagnosis. It utilizes semiconductor microelectronic processing technology to form medium-density micro-gold electrode array on the glass slide, and fixes different DNA probes on the surface of the array electrode. The specific gene of various pathogenic bacteria and the mutation of the gene related to diseases are detected by a specific DNA probe hybridization method on the surface of an electrode array. Detecting hybridization signals by an electrode electrochemical method or a laser-excited fluorescence scanning method. The invention can simultaneously detect a plurality of pathogenic bacteria and disease-related gene mutation and has the characteristics of parallel analysis and multiple analysis.
Description
The present invention relates to the detection method of a kind of pathogen and disease-correlative gene mutation DNA chip dedicated for diagnosing.
In the prior art, the detection of pathogen mainly is to utilize micro-biological process, serological method and PCR method.Existing detection method as enterohemorrhagic Escherichia coli O 157: H7 is: sample thief 25g, the mEC nutrient culture media 225ml of first day interpolation ovobiocin (increasing bacterium cultivates) (42 ℃, 18～24 hours); Added SIB agar medium (isolation medium) (35 ℃, 24 hours), and select 20 above bacterium colonies in second day; Added CLIG agar slant culture-medium (confirming to cultivate) (35 ℃, 18～24 hours) on the 3rd day and carry out O157 aggregation (seroreaction) to positive; Carried out toxin on the 4th day and produce experiment, the H type is judged.
The detection of disease-correlative gene mutation mainly contains (1) PCR-RFLP (restriction fragmentlength polymorphism), this method is utilized multiple restriction enzyme that gene amplification product is carried out enzyme and is cut, different gene orders will produce different electrophoresis pattern (Mercier, B.et al, Eur.J.lmmunogenetics, 21,105,1994).This method can only be applied to when sudden change has changed a certain restriction enzyme site.The improvement of this method is to introduce restriction enzyme site method, i.e. PCR-AIRS (Mut.Res, 285,125,1993) in the mutational site.(2) PCR-SSO (sequence specificoligonucleotide) or PCR-ASO (allele specific oligonucleotide) (Cotton, R.G.H.Mut.Res, 285,1251993; Saiki, R K et al, Nature, 324,163,1986), testing gene is behind pcr amplification, respectively with the wild type and the saltant probe hybridization of 15-20bp mark.This method need be carried out marks such as isotope labeling or digoxin, biotin, peroxidase, and the analytic process complexity is not suitable for express-analysis.(3) PCR-SSP (sequence specific primers) or ASPCR (allelespecific PCR), its principle is that the character according to the known mutations site designs a base mismatch in primer, makes it only can increase saltant or wild type gene.This method is comparatively fast and convenient.(Wu，D.Y，etal，Proc，Natl.Acad.Sci.USA，86，2757，1989；Rust，S，etal，Nucleic?AcidsResearch，21，3623，1993；Newton，R?et?al，Nucleic?Acids?Research，17，2503，1989)。(4) PCR-SSCP (single-stranded conformation polymorphism), SSCP be meant single strand dna in neutral PAGE electrophoretic mobility with the character of its conformational change, therefore can be used as the detection method of genetic mutation, be used for oncogene point mutation and people's gene group polymorphism research (Orita by Orita the earliest, M, et al, Proc Natl Acad Sci USA, 86,2766,1989), this method only can detect the existence of genetic mutation, and can not determine the position and the content of sudden change.(5) dna sequencing method, this is the most directly perceived, method the most accurately.But technical sophistication costs an arm and a leg, can not be as conventional method.
In sum, in the prior art of relevant pathogen and disease-correlative gene mutation diagnosis, have trivial operations, required time is long, and cost is higher, is difficult to problems such as robotization and great amount of samples parallel analysis.
Purpose of the present invention is exactly at the deficiencies in the prior art, proposes the detection method of a kind of pathogen and disease-correlative gene mutation DNA chip dedicated for diagnosing.
The present invention takes following measures in order to achieve the above object:
Utilize the semiconductor microelectronic processing technique on slide, form in density (＞2000/microscopeslide) little gold electrode array is fixed in array electrode surface with the self assembly technique for fixing with different dna probes with array point sample instrument (Arrayer) in the different gold electrode surfaces of electrod-array.Detect specific gene and the disease-correlative gene mutation of various pathogens with the specificity DNA probing needle hybridizing method of electrode array surface.Crossover process can freely be controlled by different electrode in the electrod-array with the hybridization zone.(electrogenerated chemiluminescence, ECL), electrode electro Chemical method or LASER Excited Fluorescence scan method detect hybridization signal with electrochemiluminescence.
Advantage of the present invention:
In a microscope slide surface, set up 10 or more regional microelectrode array (10 * 10) with the semiconductor microelectronic processing technique, therefore can detect various pathogens and disease-correlative gene mutation simultaneously.Have the multiple analysis characteristics, and the hybridization of each area array and testing process can independently be controlled and detect by electrochemical method.A kind of area array is used for the multiple relevant sudden change of several related genes of parallel repeated detection or a kind of gene, has the characteristics of parallel analysis and multiple analysis simultaneously.Stationary probe crossover process on sample DNA and the chip is accelerated in the low current pulse, and oppositely the low current pulse can be distinguished and join hybridization and the hybridization of single base mispairing entirely.Electrochemical luminous detection method does not need expensive confocal fluorescent microscope or fluorescent scanning instrument.The detection of pathogenic bacteria and disease-correlative gene mutation can foreshorten in 5 hours and finish.
Elaborate below in conjunction with drawings and Examples:
Fig. 1 is area array electrode and terminal pin synoptic diagram;
Fig. 2 is the gold-plated making synoptic diagram of area electrodes;
Fig. 3 is that the DNA special chip is made synoptic diagram;
Fig. 4 is a DNA chip hybridization control action synoptic diagram.
The manufacturing process of little gold electrode array of the present invention is: pattern Figure 11 of first design specialized chip, on slide, plate the chromium 15 of one deck 20nm with certain pattern, plate the gold 16 of one deck 200nm again at the chromium laminar surface, the mask mode that utilization designs, as insulation course 17, make up gold electrode array 13 with 2 μ m silicon nitrides in different gold thin film zones.Each area electrodes array utilizes same lead-in wire 14 and electrode change-over switch 18, can carry out galvanochemistry control 19.
Being fixed as of dna probe: with sulfydryl modification dna probe (SH-(CH
2)
6-DNA oligo), utilizes sulfhydryl compound to form self assembled monolayer character, dna probe is fixed in electrode surface in active gold surface.Or with ll-Mercaptoundecanoic acid (HS-(CH
2)
10-COOH) form self assembled monolayer in gold surface, make gold electrode surfaces have pendant carboxylic group, under EDC and NHS effect, amido modified dna probe can be fixed in the array electrode surface.
DNA chip surface crossover process is: the DNA chip of structure inserts DNA chip dedicated hybridization control enclosure, use the low electric conductivity hybridization solution, utilization to electrode and the pulse of area array electrode field current (to electrode 12 for negative, area array electrode 13 is for just), impel the DNA sample to concentrate, accelerate stationary probe crossover process on sample DNA and the chip in hybridization array electrode zone; Reverse current pulses stimulates, and removes the DNA and the base mispairing hybrid dna of non-specific adsorption.With the low current pulse action hybridization was finished in 10 minutes; Oppositely the low current pulse can be distinguished and join hybridization and the hybridization of single base mispairing entirely.
Hybridization signal detects: the present invention detects hybridization signal with two kinds of methods, uses the fluorescence labeling sample DNA for first kind, and DNA chip hybridization signal is detected with confocal fluorescent microscope or fluorescent scanning instrument in the hybridization back; Second kind is after the hybridization of non-marked sample DNA, adds specific bond double-stranded DNA reagent, as Ru (Phen)
3 2+, electrochemiluminescence detects in the presence of tri-n-propylamine.
The embodiment design is as the chip mode of Fig. 1, on glass sheet, plate the chromium 15 of one deck 20nm with this pattern,, utilize the mask mode of 10 * 10 arrays again at the gold 16 of chromium laminar surface plating one deck 200nm, as insulation course 17, make up gold electrode array 13 with 2 μ m silicon nitrides in different gold thin film zones.Make then and detect pathogenic entero becteria: toxin originality Escherichia coli, intestinal bleeding Escherichia coli O 157: H7, Salmonella, staphylococcus aureus Staphylococcus aursus, the DNA chip of the resistance to the action of a drug somatotype of vibrios Vibrio cholerae and tubercle bacillus Mycobacterium tuberculosis.
As previously mentioned, the existing method of pathogenic entero becteria detection is microbe culture and serological method.The shortcoming that life period is long, general 3～5 days.Required time for the resistance to the action of a drug somatotype of tubercle bacillus is longer, because growth of bacillus tubercle is very slow, detects and resistance to the action of a drug analysis generally needed for 6～8 weeks.Whole world mycobacterium tuberculosis infection number accounts for 1/3 of population, annual dead about 3,000,000 people.
1. several pathogenic entero becterias and tubercle bacillus resistance to the action of a drug somatotype specific DNA probe design toxin originality Escherichia coli: with heat-sensitive toxin I (LTI) and heat-sensitive toxin II (LTII) is the gene of target; Designed probe is
The probe of LTI: LTI-1, GGTCTCGGTCATATATGTGATTC and LTI-2, TAGAGAGGATAGTAACGCCGTAA is fixed in I, the III electrode position of array region 1 respectively with 5 * 5 arrays.
The probe of LTII: LTII-1, CAATAAAATCATCTTCGCTCATG and LTII-2, TTTGCTGAAACAGAAAATGATAT is respectively with II, the IV electrode position of 5 * 5 array regions 1.Intestinal bleeding Escherichia coli O 157: H7: with vero toxin stx2 gene is the gene of target, and the designed probe sequence is that GCCGTATTAACGAACCCGGG is fixed in area array 2 electrode positions.Salmonella: belonging to specificity is target sequence with 16SrDNA, and probe sequence is TGCTGCCGTTATTAACCACCACA, is fixed in I, the II electrode position of area array 6; For STyphimurirm, be the gene of target with its enterotoxin STN gene, the designed probe sequence is GATATTATTACTCACTCCCTG and GTTGCCAGTGATAGCGAGACA, is individually fixed in III, the IV electrode position of area array 6.Staphylococcus aureus: with its enterotoxin genes is the gene of target, and the designed probe sequence is TTCAGTAATGCCACCATAGGC and GTATTTTGTTTACCGTCTAGC, is individually fixed in I, the II electrode position of area array 4.Vibrios Vibrio cholerae: with the CT toxin gene is the gene of target, and designed probe is TTAAACATCCAAAGCAAGCT and TTTGGCTAAGGGCGATTGAA, is individually fixed in III, the IV electrode position of area array 4.The resistance to the action of a drug somatotype of tubercle bacillus Mycobaclerium tuberculosis: different cigarette callosity resistance to the action of a drug somatotype---area array 5
The sudden change of KatG (catalase-peroxidase) gene-correlation; The S315T detection that suddenlys change;
The sudden change of ImhA (NADH-dependent2-trans enoyl-acyl carrier protein reductase) gene-correlation
The relevant sudden change of zone line of ahpC (alkylhydroperoxide reductase) gene-correlation sudden change oxyR gene and ahpC gene: 641-GACTCTCCTCATCATCAAATGAT ATATCACACCATATTTATCGGG-745 (Genbank, Accession No.U16243), G651A, C680T, A687G, G689A, G692A, C693A/T, C695T, G715A, T717C, C722T, T727A, G729A.With primer GCTTGATGTCCGAGAGCATCG and GGTCGCGTAGGCAGTGCCCC amplification zone line segment.Rifampin resistance to the action of a drug somatotype----area array 3
The sudden change of rpoB (β subunit of RNA polymerase) gene-correlation, there is sudden change in 96% rifampicin resistance tubercle bacillus at the 81bp of rpoB gene zone line (508AAA-532AA), as His526Tyr, Ser531Leu etc.Design point sudden change distinguished sequence is fixed in area array 7.Sample increases with primer GGCCGGTGGTCGCCGCG and ACGTGACAGACCGCCGGGC.The Met306 sudden change of ethambutol (ethambutol) resistance to the action of a drug somatotype----area array 7embB gene:
(Genbank, Accession No.U68480) G AC T
C
Design detects the point mutation probe of A7868 → G/C and G7870 → A/T/C.Streptomycin resistance division----area array 8
The relevant sudden change of rrs (16s rRNA) gene: C491T, C512T, A513T, C798T, G877A, A904G and A906C.With primer GAGAGTTTGATCCTGGCTCAG and TGCACACAGGCCACAAGGGGA amplification rrs gene segment.
The relevant sudden change of RpsL (ribosomal protein S12) gene; K43R (AAG → AGG) and K88Q (AAG → CAG).With primer GGCCGACAAACAGAACGT and GTTCACCAACTGGGTGAC amplification rpsL gene segment.Pyrazinamide resistance to the action of a drug somatotype----area array 9
The sudden change of pnaA (pyranzinamidase) gene-correlation: relevant sudden change mainly concentrates on A13-C36, C205-G255 and G394-G426 section Genbank, Access ion No.U59967), the relevant mutant probe of design is fixed in area array 9.Fluoroquinolones resistance to the action of a drug somatotype----area array 10
The sudden change of gyrA (A subunit of DNA gryase) gene-correlation; Relevant sudden change mainly concentrates on 2566-GGCGACGCGTCGATCTACGACAG-2590 section (Genbank, Accession No.L27512), as G2567T, and C2574T, T2576C, G2585T/C/A, A2586G/C, G2589C.The relevant mutant probe of design is fixed in area array 10.With primer CAGCTACATCGACTATGCGA and GGGCTTCGGTGTACCTCAT amplification gyrA gene segment.
2. sample preparation:
The gene or the sudden change zone of the target that detects with the PCR primer amplification of design as detecting with fluorescent method, add the dNTP of Cy5 mark during pcr amplification.
3. chip surface hybridization and detection:
Characteristics per sample, (to electrode is negative to the current impulse between electrode and the area array electrode in utilization, the area array electrode is for just), impel the DNA sample to concentrate at the specific array electrode zone, accelerate stationary probe crossover process on sample DNA and the chip: reverse current pulses stimulates, and removes the DNA and the base mispairing hybrid dna of non-specific adsorption.Use the confocal fluorescent microscopic examination.
Like this, the DNA chip that makes up can the fast detecting pathogenic entero becteria: toxin originality Escherichia coli, intestinal bleeding Escherichia coli O 157: H7, Salmonella, staphylococcus aureus Staphylococcus aureus, the resistance to the action of a drug somatotype of vibrios Vibrio cholerae and tubercle bacillus.
Claims (4)
- The detection new method of pathogen and disease-correlative gene mutation DNA chip dedicated for diagnosing it is characterized in that utilizing the semiconductor microelectronic processing technique on slide, form in little gold electrode array of density, different gold electrode surfaces at electrod-array are fixed in the array electrode surface with the array point sample instrument with different dna probes, detect specific gene and the disease-correlative gene mutation of various pathogens with the specificity DNA probing needle hybridizing method of electrode array surface, crossover process is freely controlled by different electrode in the electrod-array with the hybridization zone, use electrochemiluminescence, electrode electro Chemical method or LASER Excited Fluorescence scan method etc. detect hybridization signal.
- 2. the detection new method of pathogen according to claim 1 and disease-correlative gene mutation DNA chip dedicated for diagnosing is characterized in that the manufacturing process of said little gold electrode array is: the mode chart of first design specialized chip [11], on slide, plate one deck chromium [15] with certain pattern, again at chromium laminar surface plating one deck gold [16], utilize the mask mode, with silicon nitride as insulation course [17], make up gold electrode array [13] in different gold thin film zones, each area electrodes array utilizes same lead-in wire [14] and electrode change-over switch [18] to carry out galvanochemistry control [19].
- 3. what it is characterized in that said dna probe according to the detection new method of claim 1 or 2 pathogens and disease-correlative gene mutation DNA chip dedicated for diagnosing fixedly is to use the sulfydryl modification dna probe, utilize sulfhydryl compound to form self assembled monolayer character in active gold surface, the self assembled monolayer that dna probe is fixed in electrod-array or forms in gold surface, make gold electrode surfaces have pendant carboxylic group, amido modified dna probe is fixed in the array electrode surface.
- 4. the detection new method according to claim 1 or 2 pathogens and disease-correlative gene mutation DNA chip dedicated for diagnosing is characterized in that said DNA chip surface crossover process is: the DNA chip of structure inserts DNA chip dedicated hybridization control enclosure, use the low electric conductivity hybridization solution, utilization is to electrode and the pulse of area array electrode field current, impel the DNA sample to concentrate, accelerate stationary probe crossover process on sample DNA and the chip in hybridization array electrode zone; Reverse current pulses stimulates, and removes the DNA and the base mispairing hybrid dna of non-specific adsorption, with the low current pulse action hybridization is finished in 10 minutes; Oppositely the low current pulse separation is joined hybridization and the hybridization of single base mispairing entirely.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 99104669 CN1273364A (en) | 1999-05-06 | 1999-05-06 | Detection method of special DNA chip for diagnosis of pathogenic bacteria and disease-related gene mutation |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 99104669 CN1273364A (en) | 1999-05-06 | 1999-05-06 | Detection method of special DNA chip for diagnosis of pathogenic bacteria and disease-related gene mutation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN1273364A true CN1273364A (en) | 2000-11-15 |
Family
ID=5271783
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 99104669 Pending CN1273364A (en) | 1999-05-06 | 1999-05-06 | Detection method of special DNA chip for diagnosis of pathogenic bacteria and disease-related gene mutation |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1273364A (en) |
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1324041A1 (en) * | 2001-11-06 | 2003-07-02 | Aventis Behring GmbH | Test system to analyze a biological fluid |
| WO2003035825A3 (en) * | 2001-10-23 | 2003-10-16 | Vision Biotech Inc U | Photovoltaic device to accelerate the interaction among biomolecules |
| CN1313621C (en) * | 2001-11-23 | 2007-05-02 | 成都市华森电子信息产业有限责任公司 | Electronic gene chip detecting method |
| WO2018126696A1 (en) * | 2017-01-03 | 2018-07-12 | 京东方科技集团股份有限公司 | Gene sequence detection chip, gene sequence detection device and gene sequence detection method |
| CN109234158A (en) * | 2018-10-08 | 2019-01-18 | 北京京东方技术开发有限公司 | Biochip and its manufacturing method, operating method, biological detection system |
-
1999
- 1999-05-06 CN CN 99104669 patent/CN1273364A/en active Pending
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2003035825A3 (en) * | 2001-10-23 | 2003-10-16 | Vision Biotech Inc U | Photovoltaic device to accelerate the interaction among biomolecules |
| EP1324041A1 (en) * | 2001-11-06 | 2003-07-02 | Aventis Behring GmbH | Test system to analyze a biological fluid |
| CN1313621C (en) * | 2001-11-23 | 2007-05-02 | 成都市华森电子信息产业有限责任公司 | Electronic gene chip detecting method |
| WO2018126696A1 (en) * | 2017-01-03 | 2018-07-12 | 京东方科技集团股份有限公司 | Gene sequence detection chip, gene sequence detection device and gene sequence detection method |
| CN109234158A (en) * | 2018-10-08 | 2019-01-18 | 北京京东方技术开发有限公司 | Biochip and its manufacturing method, operating method, biological detection system |
| US11691150B2 (en) | 2018-10-08 | 2023-07-04 | Boe Technology Group Co., Ltd. | Biological chip, manufacturing method thereof, operation method thereof, and biological detection system |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US7803544B2 (en) | Method of detecting amplification product or target nucleic acid | |
| US6391558B1 (en) | Electrochemical detection of nucleic acid sequences | |
| Tosar et al. | Electrochemical DNA hybridization sensors applied to real and complex biological samples | |
| EP2500436A1 (en) | Method, probe and kit for DNA in situ hybridation and use thereof | |
| US8143388B2 (en) | Method and test kit for quantitative determination of polynucleotides in a mixture | |
| US20040023258A1 (en) | Method and system or detecting nucleic acids | |
| US7455975B2 (en) | Electrochemical detection of nucleic acid sequences | |
| CN111363802A (en) | CircRNA small molecule marker for indicating health aging key pathway and application thereof | |
| Liu et al. | Ultrasensitive electrochemical biosensor for the detection of the mecA gene sequence in methicillin resistant strains of Staphylococcus aureus employing gold nanoparticles | |
| JP4090498B2 (en) | Nucleic acid process probe for Mycobacterium tuberculosis | |
| US7361470B2 (en) | Electrocatalytic nucleic acid hybridization detection | |
| US7271781B2 (en) | Multiplex hybridization system for identification of pathogenic mycobacterium and method of use | |
| CN1273364A (en) | Detection method of special DNA chip for diagnosis of pathogenic bacteria and disease-related gene mutation | |
| WO2014149991A1 (en) | Methods for electronic karyotyping | |
| US20140228247A1 (en) | Sequence-specific analysis of nucleic acids | |
| KR20010051353A (en) | Detection of sequence variation of nucleic acid by shifted termination analysis | |
| AU3132997A (en) | Compositions and methods for the detection of mycobacterium kansasii | |
| JP7599835B2 (en) | Primer sets, kits and methods for detecting Mycobacteroides abscessus subsp. | |
| EP1119644A4 (en) | MOLECULAR DIAGNOSIS OF GALACTOSEMIA | |
| Kara et al. | Electrochemical Genoassay Design for Allele‐Specific Detection of Toll‐Like Receptor‐2 Gene Polymorphism | |
| JP5676846B2 (en) | Primer set for specifically amplifying nucleic acids derived from Helicobacter microorganisms, and method for detecting and / or classifying said microorganisms | |
| Azmi | Novel DNA-Based Electronic Profiling Method for Selected Algae | |
| JP2006061155A (en) | Mycobacterial bacteria identification kit | |
| JP2004534536A (en) | Gram-positive bacteria detection method | |
| Pöhlmann et al. | Electrochemical Detection of RNA |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C06 | Publication | ||
| PB01 | Publication | ||
| C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
| WD01 | Invention patent application deemed withdrawn after publication |